{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:41:09Z","timestamp":1789468869620,"version":"build-2803163510"},"reference-count":122,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["RA220126"],"award-info":[{"award-number":["RA220126"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA285580"],"award-info":[{"award-number":["R01CA285580"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["75N91022R00006"],"award-info":[{"award-number":["75N91022R00006"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-23-1151048-01"],"award-info":[{"award-number":["RSG-23-1151048-01"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001237","name":"Melville Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013733","name":"Ipsen Biopharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["2023 CSS13 HBV-LIRAGE ECTZ232901"],"award-info":[{"award-number":["2023 CSS13 HBV-LIRAGE ECTZ232901"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["CSS7 AAP 2018-1 CITHEC"],"award-info":[{"award-number":["CSS7 AAP 2018-1 CITHEC"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["CSS7 AAP 2018-1"],"award-info":[{"award-number":["CSS7 AAP 2018-1"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006678","name":"Association Fran\u00e7aise pour l'Etude du Foie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006678","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ajpath.2024.08.014","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T02:21:22Z","timestamp":1727317282000},"page":"345-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Morphomolecular Pathology and Genomic Insights into the Cells of Origin of Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3213-7688","authenticated-orcid":false,"given":"Rachel V.","family":"Guest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4135-9250","authenticated-orcid":false,"given":"Benjamin","family":"Goeppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Nault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Sia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2024.08.014_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajpath.2024.08.014_bib2","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib3","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jhep.2021.01.035","article-title":"Combined hepatocellular-cholangiocarcinoma: an update","volume":"74","author":"Beaufr\u00e8ere","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib6","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep.28546","article-title":"Liver capsule: biliary tree stem cell subpopulations","volume":"64","author":"Alvaro","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib7","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1053\/j.gastro.2011.06.049","article-title":"Embryonic ductal plate cells give rise to cholangiocytes, periportal hepatocytes, and adult liver progenitor cells","volume":"141","author":"Carpentier","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.dld.2009.03.009","article-title":"New insights into liver stem cells","volume":"41","author":"Gaudio","year":"2009","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ajpath.2024.08.014_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/hep.28326","article-title":"The hepatic, biliary, and pancreatic network of stem\/progenitor cell niches in humans: a new reference frame for disease and regeneration","volume":"64","author":"Lanzoni","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrgastro.2012.23","article-title":"The biliary tree\u2014a reservoir of multipotent stem cells","volume":"9","author":"Cardinale","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib11","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1053\/j.gastro.2021.01.028","article-title":"Axin2(+) peribiliary glands in the periampullary region generate biliary epithelial stem cells that give rise to ampullary carcinoma","volume":"160","author":"Hayata","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib12","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.30210","article-title":"Neoplastic transformation of the peribiliary stem cell niche in cholangiocarcinoma arisen in primary sclerosing cholangitis","volume":"69","author":"Carpino","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib13","doi-asserted-by":"crossref","first-page":"E3806","DOI":"10.1073\/pnas.1619416114","article-title":"Biliary epithelial injury-induced regenerative response by IL-33 promotes cholangiocarcinogenesis from peribiliary glands","volume":"114","author":"Nakagawa","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2024.08.014_bib14","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib15","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2024.08.014_bib16","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jhep.2019.06.001","article-title":"Molecular and histological correlations in liver cancer","volume":"71","author":"Calderaro","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.humpath.2020.12.009","article-title":"Hepatocellular carcinoma: making sense of morphological heterogeneity, growth patterns, and subtypes","volume":"112","author":"Torbenson","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib18","series-title":"Digestive System Tumours. WHO Classification of Tumours Series","first-page":"229","article-title":"Hepatocellular carcinoma","author":"Torbenson","year":"2019"},{"key":"10.1016\/j.ajpath.2024.08.014_bib19","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2017.05.014","article-title":"Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification","volume":"67","author":"Calderaro","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib20","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1249484","article-title":"Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma","volume":"343","author":"Honeyman","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2024.08.014_bib21","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1038\/s41467-023-37951-6","article-title":"Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss","volume":"14","author":"R\u00fcland","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2024.08.014_bib22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","article-title":"EASL-ILCA clinical practice guidelines on the management of intrahepatic cholangiocarcinoma","volume":"79","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2024.08.014_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejca.2022.02.013","article-title":"Prognostic impact of FGFR2\/3 alterations in patients with biliary tract cancers receiving systemic chemotherapy: the BITCOIN study","volume":"166","author":"Rizzato","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajpath.2024.08.014_bib25","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/jnci\/djad046","article-title":"Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma","volume":"115","author":"Spencer","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajpath.2024.08.014_bib26","doi-asserted-by":"crossref","first-page":"652","DOI":"10.21037\/jgo.2018.08.18","article-title":"Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets","volume":"10","author":"Weinberg","year":"2019","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib27","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.21037\/jgo-21-776","article-title":"Specific genomic alterations and prognostic analysis of perihilar cholangiocarcinoma and distal cholangiocarcinoma","volume":"12","author":"Zheng","year":"2021","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib28","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2024.08.014_bib29","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-18-0078","article-title":"Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention","volume":"24","author":"Lowery","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2024.08.014_bib30","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.18632\/oncotarget.1943","article-title":"Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups","volume":"5","author":"Simbolo","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2024.08.014_bib31","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/PAS.0000000000000670","article-title":"Distinct clinicopathologic and genetic features of 2 histologic subtypes of intrahepatic cholangiocarcinoma","volume":"40","author":"Hayashi","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib32","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/modpathol.2013.241","article-title":"Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features","volume":"27","author":"Liau","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib33","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12885-020-06804-6","article-title":"Distinct clinical and prognostic implication of IDH1\/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma","volume":"20","author":"Ma","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ajpath.2024.08.014_bib34","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.14309\/ajg.0000000000000326","article-title":"Combined hepatocellular cholangiocarcinoma: a population-based retrospective study","volume":"114","author":"Ramai","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1440-1746.1998.tb00542.x","article-title":"Combined hepatocellular-cholangiocarcinoma: a clinicopathological study","volume":"13","author":"Ng","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib36","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1111\/liv.14261","article-title":"Combining imaging and tumour biopsy improves the diagnosis of combined hepatocellular-cholangiocarcinoma","volume":"39","author":"Gigante","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.ajpath.2024.08.014_bib37","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.jhep.2022.07.019","article-title":"Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma","volume":"77","author":"Calderaro","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib38","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/his.14622","article-title":"Is nestin a diagnostic marker for combined hepatocellular-cholangiocarcinoma?","volume":"80","author":"Sasaki","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hep.29789","article-title":"cHCC-CCA: consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation","volume":"68","author":"Brunt","year":"2018","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.ajpath.2024.08.014_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/liv.14093","article-title":"Anatomical, histomorphological and molecular classification of cholangiocarcinoma","volume":"39","author":"Kendall","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.ajpath.2024.08.014_bib41","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00292-020-00808-6","article-title":"[Cholangiocarcinoma\u2014diagnosis, classification, and molecular alterations]. German","volume":"41","author":"Goeppert","year":"2020","journal-title":"Pathologe"},{"issue":"Suppl 2","key":"10.1016\/j.ajpath.2024.08.014_bib42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00292-017-0359-9","article-title":"[Biliary tract cancers: molecular characterization and identification of novel prognostic markers]. German","volume":"38","author":"Goeppert","year":"2017","journal-title":"Pathologe"},{"key":"10.1016\/j.ajpath.2024.08.014_bib43","article-title":"Cell of origin in biliary tract cancers and clinical implications","volume":"3","author":"Moeini","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.ajpath.2024.08.014_bib44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature13441","article-title":"Mutant IDH inhibits HNF-4[alpha] to block hepatocyte differentiation and promote biliary cancer","volume":"513","author":"Saha","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2024.08.014_bib45","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1053\/j.gastro.2022.05.007","article-title":"NOTCH-YAP1\/TEAD-DNMT1 axis drives hepatocyte reprogramming into intrahepatic cholangiocarcinoma","volume":"163","author":"Hu","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib46","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/14728222.2017.1310842","article-title":"Role of the Notch signaling in cholangiocarcinoma","volume":"21","author":"Cigliano","year":"2017","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.ajpath.2024.08.014_bib47","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/hep.26721","article-title":"Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway","volume":"59","author":"Goeppert","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib48","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1080\/15592294.2016.1227899","article-title":"Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinoma","volume":"11","author":"Goeppert","year":"2016","journal-title":"Epigenetics"},{"key":"10.1016\/j.ajpath.2024.08.014_bib49","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/hep.30493","article-title":"Integrative analysis defines distinct prognostic subgroups of intrahepatic cholangiocarcinoma","volume":"69","author":"Goeppert","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib50","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2018.01.009","article-title":"Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations","volume":"68","author":"Wardell","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib51","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","article-title":"Liver cancer cell of origin, molecular class, and effects on patient prognosis","volume":"152","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib52","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/hep.25595","article-title":"Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes","volume":"55","author":"Komuta","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib53","doi-asserted-by":"crossref","first-page":"12250","DOI":"10.1073\/pnas.1600067113","article-title":"Notch3 drives development and progression of cholangiocarcinoma","volume":"113","author":"Guest","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2024.08.014_bib54","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/modpathol.3800788","article-title":"Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria","volume":"20","author":"Zen","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib55","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/hep.31110","article-title":"Genomic characterization of cholangiocarcinoma in primary sclerosing cholangitis reveals therapeutic opportunities","volume":"72","author":"Goeppert","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib56","first-page":"1167","article-title":"Clinicopathological features of \u201cintraductal papillary neoplasm of the bile duct\u201d and patient outcome after surgical resection","volume":"55","author":"Nanashima","year":"2008","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib57","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/j.1478-3231.2007.01577.x","article-title":"Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis","volume":"27","author":"Itatsu","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.ajpath.2024.08.014_bib58","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jhep.2005.09.025","volume":"44","author":"Zen","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/modpathol.2013.112","article-title":"Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways","volume":"27","author":"Schlitter","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib60","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.21387","article-title":"Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas","volume":"44","author":"Zen","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib61","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/gutjnl-2020-322983","article-title":"Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis","volume":"71","author":"Goeppert","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2024.08.014_bib62","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.3390\/cancers13112742","article-title":"Whole exome sequencing of biliary tubulopapillary neoplasms reveals common mutations in chromatin remodeling genes","volume":"13","author":"Gross","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajpath.2024.08.014_bib63","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/his.14103","article-title":"Biliary intraductal tubule-forming neoplasm: a whole exome sequencing study of MUC5AC-positive and -negative cases","volume":"76","author":"Akita","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib64","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1038\/s41467-021-25012-9","article-title":"Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer","volume":"12","author":"Lin","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2024.08.014_bib65","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/path.5514","article-title":"miRNA profiling of biliary intraepithelial neoplasia reveals stepwise tumorigenesis in distal cholangiocarcinoma via the miR-451a\/ATF2 axis","volume":"252","author":"Loeffler","year":"2020","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib66","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/hep.31585","article-title":"Epigenome-wide analysis of methylation changes in the sequence of gallstone disease, dysplasia, and gallbladder cancer","volume":"73","author":"Br\u00e4gelmann","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib67","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78636","article-title":"Gallbladder adenocarcinomas undergo subclonal diversification and selection from precancerous lesions to metastatic tumors","volume":"11","author":"Kang","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.ajpath.2024.08.014_bib68","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/hep.32125","article-title":"Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile","volume":"75","author":"Vedeld","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib69","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0038-1655775","article-title":"Emerging technologies for the diagnosis of perihilar cholangiocarcinoma","volume":"38","author":"Ilyas","year":"2018","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ajpath.2024.08.014_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100358","article-title":"Gene rearrangement and expression of PRKACA and PRKACB govern morphobiology of pancreatobiliary oncocytic neoplasms","volume":"37","author":"Itoh","year":"2024","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib71","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41379-019-0398-2","article-title":"DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma","volume":"33","author":"Vyas","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib72","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1053\/j.gastro.2019.10.028","article-title":"Recurrent rearrangements in PRKACA and PRKACB in intraductal oncocytic papillary neoplasms of the pancreas and bile duct","volume":"158","author":"Singhi","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib73","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ccell.2017.05.009","article-title":"Common molecular subtypes among Asian hepatocellular carcinoma and cholangiocarcinoma","volume":"32","author":"Chaisaingmongkol","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2024.08.014_bib74","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","article-title":"Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma","volume":"7","author":"Jusakul","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ajpath.2024.08.014_bib75","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1136\/gutjnl-2023-330483","article-title":"Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies","volume":"73","author":"Hong","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2024.08.014_bib76","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-3-031-35166-2_4","article-title":"The hallmarks of liver fluke related cholangiocarcinoma: insight into drug target possibility","volume":"219","author":"Loilome","year":"2023","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.ajpath.2024.08.014_bib77","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ajpath.2024.08.014_bib78","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41576-020-0223-2","article-title":"Lineage tracing meets single-cell omics: opportunities and challenges","volume":"21","author":"Wagner","year":"2020","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ajpath.2024.08.014_bib79","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cell.2012.01.002","article-title":"Lineage tracing","volume":"148","author":"Kretzschmar","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2024.08.014_bib80","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.stem.2014.09.008","article-title":"Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes","volume":"15","author":"Tarlow","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ajpath.2024.08.014_bib81","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41586-018-0075-5","article-title":"De novo formation of the biliary system by TGF[beta]-mediated hepatocyte transdifferentiation","volume":"557","author":"Schaub","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2024.08.014_bib82","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.15034","article-title":"Heterogeneity and stochastic growth regulation of biliary epithelial cells dictate dynamic epithelial tissue remodeling","volume":"5","author":"Kamimoto","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.ajpath.2024.08.014_bib83","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/hep.20650","article-title":"Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis","volume":"41","author":"Clouston","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib84","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/ncb3203","article-title":"Hepatic progenitor cells of biliary origin with liver repopulation capacity","volume":"17","author":"Lu","year":"2015","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib85","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tcb.2020.01.007","article-title":"Cell plasticity in liver regeneration","volume":"30","author":"Li","year":"2020","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib86","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1158\/0008-5472.CAN-13-1911","article-title":"Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma","volume":"74","author":"Guest","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2024.08.014_bib87","doi-asserted-by":"crossref","DOI":"10.1038\/srep23899","article-title":"A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion","volume":"6","author":"Ikenoue","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2024.08.014_bib88","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/dvg.20397","article-title":"A CK19(CreERT) knockin mouse line allows for conditional DNA recombination in epithelial cells in multiple endodermal organs","volume":"46","author":"Means","year":"2008","journal-title":"Genesis"},{"key":"10.1016\/j.ajpath.2024.08.014_bib89","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1158\/0008-5472.CAN-17-1123","article-title":"Kras and Tp53 mutations cause cholangiocyte- and hepatocyte-derived cholangiocarcinoma","volume":"78","author":"Hill","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2024.08.014_bib90","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ng.722","article-title":"Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine","volume":"43","author":"Furuyama","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2024.08.014_bib91","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/sj.gt.3300947","article-title":"Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA","volume":"6","author":"Liu","year":"1999","journal-title":"Gene Ther"},{"key":"10.1016\/j.ajpath.2024.08.014_bib92","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.gt.3302865","article-title":"Structural impact of hydrodynamic injection on mouse liver","volume":"14","author":"Suda","year":"2007","journal-title":"Gene Ther"},{"key":"10.1016\/j.ajpath.2024.08.014_bib93","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1172\/JCI63212","article-title":"Cholangiocarcinomas can originate from hepatocytes in mice","volume":"122","author":"Fan","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2024.08.014_bib94","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1038\/s41388-018-0188-1","article-title":"Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice","volume":"37","author":"Wang","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2024.08.014_bib95","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1053\/j.gastro.2024.05.033","article-title":"Human hepatocytes can give rise to intrahepatic cholangiocarcinomas","volume":"167","author":"Hsu","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib96","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1172\/JCI63065","article-title":"Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes","volume":"122","author":"Sekiya","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2024.08.014_bib97","doi-asserted-by":"crossref","first-page":"8248","DOI":"10.1073\/pnas.0912203107","article-title":"The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis","volume":"107","author":"Lee","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2024.08.014_bib98","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1073\/pnas.0911427107","article-title":"Hippo signaling is a potent in\u00a0vivo growth and tumor suppressor pathway in the mammalian liver","volume":"107","author":"Lu","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2024.08.014_bib99","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.cell.2016.05.058","article-title":"p53-Dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer","volume":"165","author":"Tschaharganeh","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2024.08.014_bib100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41586-018-0519-y","article-title":"Necroptosis microenvironment directs lineage commitment in liver cancer","volume":"562","author":"Seehawer","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2024.08.014_bib101","first-page":"255","article-title":"Translating cancer genomics for precision oncology in biliary tract cancers","volume":"28","author":"Haber","year":"2019","journal-title":"Discov Med"},{"key":"10.1016\/j.ajpath.2024.08.014_bib102","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2020.03.008","article-title":"Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma","volume":"73","author":"Montal","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib103","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1038\/s41467-022-30708-7","article-title":"The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2024.08.014_bib104","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2017.01.010","article-title":"Mixed hepatocellular cholangiocarcinoma tumors: cholangiolocellular carcinoma is a distinct molecular entity","volume":"66","author":"Moeini","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib105","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ccell.2019.04.007","article-title":"Genomic and transcriptomic profiling of combined hepatocellular and intrahepatic cholangiocarcinoma reveals distinct molecular subtypes","volume":"35","author":"Xue","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2024.08.014_bib106","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/path.5243","article-title":"Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma","volume":"248","author":"Joseph","year":"2019","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib107","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/s41467-018-03276-y","article-title":"Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma","volume":"9","author":"Wang","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2024.08.014_bib108","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1053\/j.gastro.2015.05.061","article-title":"Genetic landscape and biomarkers of hepatocellular carcinoma","volume":"149","author":"Zucman-Rossi","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib109","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/bs.acr.2022.01.008","article-title":"Novel insights into molecular and immune subtypes of biliary tract cancers","volume":"156","author":"Bramel","year":"2022","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.ajpath.2024.08.014_bib110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib111","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/gutjnl-2021-326514","article-title":"Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications","volume":"72","author":"Martin-Serrano","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2024.08.014_bib112","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/hep.31092","article-title":"Identification of four immune subtypes characterized by distinct composition and functions of tumor microenvironment in intrahepatic cholangiocarcinoma","volume":"72","author":"Job","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.08.014_bib113","first-page":"647","article-title":"Combined liver cell and bile duct carcinoma","volume":"25","author":"Allen","year":"1949","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib114","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature14221","article-title":"Cell-of-origin chromatin organization shapes the mutational landscape of cancer","volume":"518","author":"Polak","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2024.08.014_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113446","article-title":"Genome-wide profiling of transcription factor activity in primary liver cancer using single-cell ATAC sequencing","volume":"42","author":"Craig","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.ajpath.2024.08.014_bib116","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/s41467-022-29164-0","article-title":"Single-cell transcriptomic analysis suggests two molecularly subtypes of intrahepatic cholangiocarcinoma","volume":"13","author":"Song","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2024.08.014_bib117","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3558200","article-title":"Characterization of immunogenicity of malignant cells with stemness in intrahepatic cholangiocarcinoma by single-cell RNA sequencing","volume":"2022","author":"Bian","year":"2022","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.ajpath.2024.08.014_bib118","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ccell.2019.08.007","article-title":"Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer","volume":"36","author":"Ma","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2024.08.014_bib119","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jhep.2021.06.028","article-title":"Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"75","author":"Ma","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2024.08.014_bib120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s13238-021-00868-1","article-title":"Cancer biology deciphered by single-cell transcriptomic sequencing","volume":"13","author":"Li","year":"2022","journal-title":"Protein Cell"},{"key":"10.1016\/j.ajpath.2024.08.014_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2023.102196","article-title":"A marker gene-based method for identifying the cell-type of origin from single-cell RNA sequencing data","volume":"10","author":"Nouri","year":"2023","journal-title":"MethodsX"},{"key":"10.1016\/j.ajpath.2024.08.014_bib122","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.jhep.2023.08.017","article-title":"Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab\/bevacizumab","volume":"79","author":"Limousin","year":"2023","journal-title":"J Hepatol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944024003572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944024003572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T01:09:50Z","timestamp":1772327390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944024003572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":122,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0002944024003572"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2024.08.014","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morphomolecular Pathology and Genomic Insights into the Cells of Origin of Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2024.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}